Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
St. Luke's Health Baylor College of Medicine
mi
from
Houston, TX
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
St. Luke's Health Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Bon Secours Mary Immaculate Hospital
mi
from
Newport News, VA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Bon Secours Mary Immaculate Hospital
mi
from
Newport News, VA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Bon Secours St. Mary's Hospital
mi
from
Richmond, VA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Bon Secours St. Mary's Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Mcguire Dvamc
mi
from
Richmond, VA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
FSU Hypertension Self-Care Training Study
Improving the Willpower-based Self-care for Hypertension
Status: Enrolling
Updated:  7/30/2015
FSU College of Social Work
mi
from
Tallahassee, FL
FSU Hypertension Self-Care Training Study
Improving the Willpower-based Self-care for Hypertension
Status: Enrolling
Updated: 7/30/2015
FSU College of Social Work
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Foley, AL
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Foley, AL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Buena Park, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Buena Park, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Carmichael, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Carmichael, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Fresno, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Irvine, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Lomita, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Paramount, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Paramount, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Sacramento, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
San Diego, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Wildomar, CA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Wildomar, CA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Milford, CT
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Milford, CT
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Milford, CT
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Milford, CT
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Miami, FL
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Miami, FL
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Tallahassee, FL
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Tampa, FL
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Dunwoody, GA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Dunwoody, GA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Roswell, GA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Roswell, GA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Suwanee, GA
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Suwanee, GA
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Avon, IN
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Avon, IN
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Lexington, KY
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Biddeford, ME
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Biddeford, ME
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Biddeford, ME
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Biddeford, ME
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Saint Peters, MO
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
St. Louis, MO
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
St. Louis, MO
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
St. Peters, MO
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
St. Peters, MO
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Henderson, NV
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Glens Falls, NY
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Greensboro, NC
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Salisbury, NC
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Shelby, NC
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Shelby, NC
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Fargo, ND
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Effect of Febuxostat on Blood Pressure
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials